Remove Biopharma Remove Biopharmaceuticals Remove Biotechnology Remove IT partnerships
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. FUJIFILM Diosynth Biotechnologies invested $1.6 SCHOTT Pharma announced expansion plans in the US to meet the growing demand for mRNA vaccines, GLP1 drugs, and biologics.